Alzheimer's and dementia: What's the difference? - Mayo Clinic
WEBMar 13, 2024 · Mixed dementia. While dementia is a general term, Alzheimer's disease is a specific brain disease. It is marked by symptoms of dementia that gradually get worse over time. Alzheimer's disease first affects the part of the brain associated with learning, so early symptoms often include changes in memory, thinking and reasoning skills.
Alzheimer's disease - Symptoms and causes - Mayo Clinic
WEBJul 10, 2024 · It's characterized by changes in the brain that lead to deposits of certain proteins. Alzheimer's disease causes the brain to shrink and brain cells to eventually die. Alzheimer's disease is the most common cause of dementia — a gradual decline in memory, thinking, behavior and social skills. These changes affect …
Alzheimer's stages: How the disease progresses - Mayo Clinic
WEBJun 7, 2023 · Memory, thinking, judgment, language, problem-solving, personality and movement can all be affected by the disease. There are five stages associated with Alzheimer's disease. They include: Preclinical Alzheimer's disease. Mild cognitive impairment due to Alzheimer's disease. Mild dementia due to Alzheimer's disease.
Young-onset Alzheimer's: When symptoms begin before age 65
WEBApr 10, 2024 · Young-onset Alzheimer's disease is an uncommon form of dementia that affects people younger than age 65. The condition also is called early-onset Alzheimer's disease. Most people with Alzheimer's are age 65 and older. About 1 in 9 people age 65 and older in the United States has Alzheimer's disease. About 110 …
Frontotemporal dementia - Symptoms and causes - Mayo Clinic
WEBNov 28, 2023 · Frontotemporal dementia can be misdiagnosed as a mental health condition or as Alzheimer's disease. But FTD tends to occur at a younger age than does Alzheimer's disease. It often begins between the ages of 40 and 65, although it can occur later in life as well. FTD is the cause of dementia about 10% to 20% of the time.
Alzheimer's: Medicines help manage symptoms and slow decline
WEBJul 10, 2024 · Memantine (Namenda) is a medicine that limits glutamate-cell interactions. Memantine may help slow the decline in memory and thinking skills. It also may play a role in protecting nerve cells. Memantine is approved to treat moderate to …
Primary progressive aphasia - Symptoms and causes - Mayo Clinic
WEBApr 1, 2023 · Primary progressive aphasia (uh-FAY-zhuh) is a rare nervous system syndrome that affects the ability to communicate. People who have it can have trouble expressing their thoughts and understanding or finding words. Symptoms begin gradually, often before age 65. They get worse over time. People with …
Symptoms and causes - Mayo Clinic
WEBMixed dementia. Autopsy studies of the brains of people age 80 and older who had dementia indicate that many had a combination of several causes. People with mixed dementia can have Alzheimer's disease, vascular dementia and Lewy body dementia. Studies are ongoing to determine how having mixed …
Alzheimer's treatments: What's on the horizon? - Mayo Clinic
WEBJul 10, 2024 · These Alzheimer's treatments boost the performance of chemicals in the brain that carry information from one brain cell to another. They include cholinesterase inhibitors and the medicine memantine (Namenda). However, these treatments don't stop the underlying decline and death of brain cells. As …
Did the definition of Alzheimer's disease change? - Mayo Clinic
WEBNov 4, 2022 · The National Institute on Aging and the Alzheimer's Association have made changes to the research definition of Alzheimer's disease dementia. The changes include criteria to define what Alzheimer's disease dementia is and who has it. But the changes apply only to clinical trials and research. The changes …